1541 related articles for article (PubMed ID: 12508260)
41. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
42. [Changes in coagulation parameters during the clinical courses of recipients of living-related partial liver transplantation].
Okumura N; Matsuzawa A; Terasawa F; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S; Makuuchi M
Rinsho Byori; 1995 Aug; 43(8):829-35. PubMed ID: 7474443
[TBL] [Abstract][Full Text] [Related]
43. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
44. Posttrauma coagulation and fibrinolysis.
Gando S; Tedo I; Kubota M
Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
[TBL] [Abstract][Full Text] [Related]
45. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
[TBL] [Abstract][Full Text] [Related]
46. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
47. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
Collatos C; Barton MH; Prasse KW; Moore JN
J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
[TBL] [Abstract][Full Text] [Related]
48. [Study of hemostatic molecular marker].
Wada H; Ioka M
Rinsho Byori; 1997 Apr; 45(4):310-4. PubMed ID: 9136593
[TBL] [Abstract][Full Text] [Related]
49. Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation.
Chung S; Kim JE; Kim JY; Lee DS; Han KS; Kim HK
Thromb Res; 2010 Jun; 125(6):e285-93. PubMed ID: 20185166
[TBL] [Abstract][Full Text] [Related]
50. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
51. [Hemostatic abnormalities in DIC].
Wada H
Rinsho Byori; 2002 Aug; 50(8):768-72. PubMed ID: 12373812
[TBL] [Abstract][Full Text] [Related]
52. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
Matsuo T; Matsuo M; Sugimoto T; Wanaka K
Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
[TBL] [Abstract][Full Text] [Related]
53. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
54. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
[TBL] [Abstract][Full Text] [Related]
55. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
56. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
57. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
[TBL] [Abstract][Full Text] [Related]
58. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
59. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
60. [Coagulation and fibrinolysis in pregnancy].
Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
